Clinical Trial Update: [18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial [EARLY_Phase 1]

View source ↗

Summary

The EARLY Phase 1 study of [18F]Fluoroestradiol-PET/CT as companion imaging to the FORESEE trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• [18F]Fluoroestradiol (fluoroestradiol (18F))

Snippet

Sponsor: University of Utah | Conditions: Estrogen Receptor Positive Breast Cancer | EARLY_Phase 1 | Status: TERMINATED